ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 622

Gut Microbiota Variations Correlate with Disease Activity in Spondyloarthritis (SpA) and Rheumatoid Arthritis (RA)

Julien Tap1,2, Jad Abou-Ghantous1, Ariane Leboime3, Roula Said Nahal3, Philippe Langella1, Henri-Jean Garchon4, Gilles Chiocchia5, Jean-Pierre Furet1 and Maxime Breban3,4, 1UMR INRA-AgroParisTech 1319, Equipe ProbiHote, MICALIS Institute, National Institute for Agronomical research (INRA), Jouy-en-Josas, France, 2Metagenopolis, INRA, Jouy-en-Josas, France, 3Service de Rhumatologie, Hopital Ambroise Pare, Boulogne-Billancourt, France, 4INSERM U987, Faculté des Sciences de la Santé Simone Veil, Montigny-le-Bretonneux, France, 5Versailles Saint Quentin en Yvelines University, INSERM U987, UFR des Sciences de la Santé, Montigny-le-Bretonneux, France

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Disease Activity, microbiome, rheumatoid arthritis (RA) and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology

Session Type: Abstract Submissions (ACR)

Background/Purpose

Inflammatory bowel diseases (IBD) are associated with changes in microbiota which may be responsible for sustained gut inflammation and/or a consequence of it. Whether variations in microbiota also play a role during the course of inflammatory rheumatic disorders such as SpA or RA, remains to be addressed.

Methods

Targeted metagenomic profiles were established by deeply sequencing the 16S rRNA-encoding bacterial genes amplified by PCR in stools from 97 SpA and 33 RA patients, and 72 healthy controls (including 46 siblings of SpA patients). After pyrosequencing and a denoizing step to remove artefactual reads, bacterial operational taxonomic units (OTUs) were attributed to the remaining sequences (>1.5M reads, 8,000 sequences per sample in average). Supervised analysis (between class co-inertia analysis and L1-regularized logistic machine learning procedure) was carried out to identify factors associated with OTUs variations. Age, gender, disease status and activity (SpA: BASDAI; RA: DAS28) and concomitant treatments (NSAIDs, corticosteroids, DMARDs, biotherapies) were the considered variables.

Results

Neither SpA nor RA status correlated with discrete OTUs variations. Using 600 OTUs represented in at least 1% of the reads mass per sample, disease activity was the main clinical factor explaining variations in OTUs composition, similarly in SpA and RA. Concomitant treatments, and particularly corticosteroids, had also significant impact but of lesser magnitude.

Figure 1: Supervised co-inertia analysis between clinical metadata and microbial OTUs variation as function of health status. A) Health statuses are plotted according the two main components. Monte Carlo test showed that health statuses were significantly linked with clinical metadata and microbiota OTUs variations (colored according their phylum assignation). B) Principal components allowed to significantly separate patients according to disease activity and corticosteroid intake.

Figure 2: A. Complementary to this signal, SpA and RA could be distinguished from controls by combining 16 OTUs, yielding a statistically significant ROC curve (AUC = 0.69). B. The best model to predict disease activity included 110 OTUs and yielded a statistically significant ROC curve (AUC = 0.68).

Conclusion

Variations in OTUs were found both in SpA and RA, as compared to healthy controls that primarily correlated with disease activity. Whether such variations are cause or consequence of chronic joint inflammation remains to be determined.


Disclosure:

J. Tap,
None;

J. Abou-Ghantous,
None;

A. Leboime,
None;

R. Said Nahal,
None;

P. Langella,
None;

H. J. Garchon,
None;

G. Chiocchia,
None;

J. P. Furet,
None;

M. Breban,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gut-microbiota-variations-correlate-with-disease-activity-in-spondyloarthritis-spa-and-rheumatoid-arthritis-ra/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology